FRANKFURT, Aug 9 (Reuters) - BioNTech and partner
Pfizer have supplied more than one billion doses of
their COVID-19 vaccine as per July 21, a bigger number than
delivered by competitor AstraZeneca, the German biotech
group said on Monday.
AstraZeneca said on July 29 that it and its
manufacturing partner, India-based Serum Institute, had supplied
a billion doses to 170 countries at the time.
Based on delivery contracts so far, BioNTech said in a
statement it expects 15.9 billion euros ($18.7 billion) in
revenue accruing to it from the vaccine this year, up from a
forecast in May of 12.4 billion euros.
That includes sales, milestone payments from partners and a
share of gross profit in its partners' territories, the company
added.
($1 = 0.8509 euros)
(Reporting by Ludwig Burger
Editing by Caroline Copley)